Brochure
17 Jul 2026

Morning Shine Product Catalog

PDF 7.3 MB


Morning Shine Pharma specializes in the supply of upstream core raw materials and biotechnology products for peptide, XDC, and nucleic acid therapeutics. We also provide custom chemical synthesis and CMO services, supporting projects from early development through GMP manufacturing.
Our portfolio includes industry-leading monodispersed PEGs and derivatives, with PEG24 homolog impurities controlled below 0.15%, enabling improved performance in ADC, peptide, and oligonucleotide drug development.
We are also a leading supplier of peptide side chains and short peptides, with the largest production capacity for side chains and short peptides in China, high quality standards, and GMP-compliant manufacturing.
In the field of nucleic acid therapeutics, we offer high-quality GalNAc and Unylinker, with GalNAc purity above 99% and single impurities below 0.10%.

Content provided by our supplier

Changsha Morning Shine Co., Ltd.

  • Country/Region:
    China
  • Founded:
    2019
  • On CPHI since:
    2025
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator

Other Content from Changsha Morning Shine Co., Ltd. ()